The use of hydroxychloroquine as a systemic treatment in erosive lichen planus of the vulva and vagina

H A B Vermeer, H Rashid, M D Esajas, J M Oldhoff*, B Horváth

*Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

8 Downloads (Pure)


Erosive lichen planus affecting the vulva and vagina (ELPV) is a rare inflammatory skin disease, presenting with painful erosions and severe scarring.1 The disease course is persistent and often refractory to treatment: up to 45% patients do not experience remission with topical treatments, while evidence for systemic treatments remains scarce.2 Hydroxychloroquine (HCQ) is frequently used in daily practice as a first choice systemic therapy.3 However, little evidence is available on HCQ for ELPV.2 The aim of this study was to analyse the effectiveness and safety of HCQ in ELPV.

Original languageEnglish
Number of pages2
JournalThe British journal of dermatology
Early online date6-Feb-2021
Publication statusPublished - 23-Mar-2021

Cite this